Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Intangibles (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Intangibles for 8 consecutive years, with $39368.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Intangibles fell 36.18% year-over-year to $39368.0, compared with a TTM value of $39368.0 through Dec 2025, down 36.18%, and an annual FY2025 reading of $44946.0, down 33.18% over the prior year.
  • Intangibles was $39368.0 for Q4 2025 at Neuroone Medical Technologies, down from $44946.0 in the prior quarter.
  • Across five years, Intangibles topped out at $145365.0 in Q1 2021 and bottomed at $39368.0 in Q4 2025.
  • Average Intangibles over 5 years is $89870.4, with a median of $89577.0 recorded in 2023.
  • The sharpest move saw Intangibles decreased 14.78% in 2021, then crashed 36.18% in 2025.
  • Year by year, Intangibles stood at $128628.0 in 2021, then decreased by 17.35% to $106313.0 in 2022, then fell by 20.99% to $83998.0 in 2023, then fell by 26.57% to $61683.0 in 2024, then plummeted by 36.18% to $39368.0 in 2025.
  • Business Quant data shows Intangibles for NMTC at $39368.0 in Q4 2025, $44946.0 in Q3 2025, and $50525.0 in Q2 2025.